These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36813620)

  • 1. Re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.08.007.
    Gandaglia G; Briganti A; Raggi D; Marandino L; Necchi A; Di Maio M; Montorsi F
    Eur Urol Focus; 2024 May; 10(3):497. PubMed ID: 36813620
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Giorgio Gandaglia, Alberto Briganti, Daniele Raggi, et al's Letter to the Editor re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.08.007.
    Hoeh B; Chun FKH; Mandel P
    Eur Urol Focus; 2024 May; 10(3):498. PubMed ID: 36813619
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Ragheed Saoud, Varat Woranisarakul, Gladell P. Paner, et al. Physician Perception of Grade Group 1 Prostate Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.002.
    Gandaglia G; Barletta F; Briganti A; Montorsi F
    Eur Urol Focus; 2024 Jan; 10(1):205. PubMed ID: 37455217
    [No Abstract]   [Full Text] [Related]  

  • 4. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis.
    Mandel P; Hoeh B; Wenzel M; Preisser F; Tian Z; Tilki D; Steuber T; Karakiewicz PI; Chun FKH
    Eur Urol Focus; 2023 Jan; 9(1):96-105. PubMed ID: 36058809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.06.002.
    Montorsi F; Larcher A; Capitanio U
    Eur Urol Focus; 2021 Mar; 7(2):406. PubMed ID: 31564640
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review, meta-analysis, and network meta-analysis.
    Matsukawa A; Rajwa P; Kawada T; Bekku K; Laukhtina E; Klemm J; Pradere B; Mori K; Karakiewicz PI; Kimura T; Chlosta P; Shariat SF; Yanagisawa T
    Int J Clin Oncol; 2024 Jun; 29(6):716-725. PubMed ID: 38582807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Yash S. Khandwala, Simon John Christoph Soerensen, Shravan Morisetty, et al. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.10.010.
    Gravina C; Lombardo R; De Nunzio C
    Eur Urol Focus; 2023 Sep; 9(5):851-852. PubMed ID: 37005167
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Christian Moro, Charlotte Phelps, Vineesha Veer, et al. Cranberry Juice, Cranberry Tablets, or Liquid Therapies for Urinary Tract Infection: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.07.002.
    Joshi A; Tzelves L; Tandogdu Z; Juliebø-Jones P; Somani B
    Eur Urol Focus; 2024 Sep; ():. PubMed ID: 39341717
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Georges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, et al. A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.008.
    Gravina C; Lombardo R; De Nunzio C
    Eur Urol Focus; 2024 Jan; 10(1):206-207. PubMed ID: 37541916
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Bara Barakat, Hazem Othman, Ulrich Gauger, Ingmar Wolff, Boris Hadaschik, Christian Rehme. Retzius Sparing Radical Prostatectomy Versus Robot-assisted Radical Prostatectomy: Which Technique Is More Beneficial for Prostate Cancer Patients (MASTER Study)? A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.08.003.
    Kalampokis N; Grivas N; Karavitakis M; Leotsakos I; Katafigiotis I; van der Poel H
    Eur Urol Focus; 2022 Sep; 8(5):1554-1555. PubMed ID: 34930714
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis.
    Yanagisawa T; Rajwa P; Kawada T; Mori K; Fukuokaya W; Petrov P; Quhal F; Laukhtina E; von Deimling M; Bianchi A; Majdoub M; Pradere B; Kramer G; Kimura T; Shariat SF
    J Urol; 2023 Sep; 210(3):416-429. PubMed ID: 37339479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Marcin Miszczyk, Pawel Rajawa, Takafumi Yanagisawa, et al. The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies. Eur Urol. 2024;85:125-38.
    Fodor A; Brombin C; Chiti A; Di Muzio N
    Eur Urol; 2024 Oct; 86(4):e93-e94. PubMed ID: 38480110
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.01.002: New Evidence Changing Clinical Practice or Misunderstanding of Statistical Analyses? The Case of Serenoa repens and α-Blockers.
    De Nunzio C; Novara G; Damiano R; Bartoletti R; Tubaro A; Ficarra V;
    Eur Urol Focus; 2021 Jul; 7(4):894-896. PubMed ID: 32418876
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: K.R. Seetharam Bhat, Marcio Covas Moschovas, Marco Sandri, et al. Outcomes of Salvage Robot-assisted Radical Prostatectomy After Focal Ablation for Prostate Cancer in Comparison to Primary Robot-assisted Radical Prostatectomy: A Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.005.
    Montorsi F; Stabile A; Gandaglia G; Briganti A
    Eur Urol Focus; 2022 Nov; 8(6):1868. PubMed ID: 35190294
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Carmen Gravina, Riccardo Lombardo, and Cosimo De Nunzio's Letter to the Editor re: Yash S. Khandwala, Simon John Christoph Soerensen, Shravan Morisetty, et al. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.10.010.
    Sonn G; Khandwala Y
    Eur Urol Focus; 2023 Sep; 9(5):822-823. PubMed ID: 37012086
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Alessandro Uleri, Jean Nicolas Cornu, Andrea Gobbo, et al. Association of 5α-Reductase Inhibitors with Depression and Suicide: A Mini Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.04.009.
    Nguyen DD; Bhojani N; Trinh QD
    Eur Urol Focus; 2024 Jul; ():. PubMed ID: 38997837
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Carmen Gravina, Riccardo Lombardo, and Cosimo De Nunzio's Letter to the Editor re: Georges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, et al. A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.008.
    Mjaess G; Roumeguère T; Diamand R
    Eur Urol Focus; 2024 Jan; 10(1):75-76. PubMed ID: 37543515
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Cathrine Alvær Vinje, Maria Nyre Vigmostad, Svein R. Kjosavik, Henrik Grönberg, Bjørnar Gilje, Svein Skeie. Prostate Biopsies Can Be Omitted in Most Patients with a Positive Stockholm3 Test and Negative Prostate Magnetic Resonance Imaging. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.08.009.
    Liu W; He Y; Yang B
    Eur Urol Focus; 2024 Mar; 10(2):244-245. PubMed ID: 38290858
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Sarah R. Ottenhof, Andrew Leone, Rosa S. Djajadiningrat, et al. Surgical and Oncological Outcomes in Patients After Vascularized Flap Reconstruction for Locoregionally Advanced Penile Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2018.02.002.
    Innocenti A; Melita D; Ghezzi S
    Eur Urol Focus; 2019 Nov; 5(6):1157. PubMed ID: 29674120
    [No Abstract]   [Full Text] [Related]  

  • 20. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer: Updated Network Meta-analysis Stratified by Disease Volume.
    Hoeh B; Garcia CC; Wenzel M; Tian Z; Tilki D; Steuber T; Karakiewicz PI; Chun FKH; Mandel P
    Eur Urol Focus; 2023 Sep; 9(5):838-842. PubMed ID: 37055323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.